Fundraising FoxNielsen BioSciences
San Diego, US · Founded 2013 · Delaware corporation
Find your way into Nielsen BioSciences
Sign up to see every warm intro you have to Nielsen BioSciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nielsen BioSciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nielsen BioSciences develops biopharmaceutical products that assess or treat immune responses, including skin test antigens for Valley Fever and candida infections, and investigational therapeutics for HPV-related lesions.
Founders & leadership
Nielsen BioSciences was founded in 2013 by H. Stewart Nielsen, Jr. and Harry S. Nielsen, Jr..
HS
H. Stewart Nielsen, Jr.Founder and Director
HS
Harry S. Nielsen, Jr.President and CEO (at founding)
SN
Scott NielsenExecutiveScott Nielsen is an executive with more than 30 years of experience in global organizations, having worked in roles spanning strategy, talent, culture, and governance.
NL
Nelson LugoExecutive
TR
Thomas R CarpenterExecutive
Board
GJ
Gene J OstrowBoard director
GC
Grover C WrennBoard director
JG
John G RobyBoard director
RE
Robert E EschBoard director
DE
David E Thomas, Jr.Board director
Reported raises · per SEC filings
Form D private placements$11.8M disclosed across 2 rounds · 2016–2021
▶$8.4MraisedAug 2021 · 60 investors · BiotechnologyRule 506(b)
▶$8.4MraisedAug 2021 · 60 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- DAVID E. THOMAS, JR.Director
- STEWART SCOTT NIELSENExecutive Officer
- HARRY STEWART NIELSEN, JR.Director
- GROVER WRENNExecutive Officer, Director
- JOHN G. ROBYDirector
- DAVID P. BURNEYExecutive Officer
- ROBERT E. ESCHDirector
- BRUCE F. MACKLERDirector
- GENE J. OSTROWDirector
- Offering amount
- $10M
- Amount sold
- $8.4M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedSep 2016 · 65 investors · BiotechnologyRule 506(b)
▶$3.4MraisedSep 2016 · 65 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott NielsenExecutive Officer
- Gene J OstrowDirector
- Grover C WrennDirector
- Harry Stewart Nielsen, Jr.Director
- Nelson LugoExecutive Officer
- Thomas R CarpenterExecutive Officer, Director
- John G RobyDirector
- Robert E EschDirector
- David E Thomas, Jr.Director
- Offering amount
- $3.5M
- Amount sold
- $3.4M
- Minimum investment
- $1K
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Nielsen BioSciences do?
- Nielsen BioSciences develops biopharmaceutical products that assess or treat immune responses, including skin test antigens for Valley Fever and candida infections, and investigational therapeutics for HPV-related lesions.
- Who founded Nielsen BioSciences?
- Nielsen BioSciences was founded by H. Stewart Nielsen, Jr., Harry S. Nielsen, Jr. in 2013.
- How much funding has Nielsen BioSciences raised?
- Nielsen BioSciences has disclosed $11.8M raised across 2 rounds.
- Where is Nielsen BioSciences headquartered?
- Nielsen BioSciences is headquartered in San Diego, US.